Morphic Therapeutic
Michaela Mentzer is an experienced research professional currently serving as a Senior Research Associate at Morphic Therapeutic since July 2020. Previously, Michaela gained valuable experience as a Biology Co-op at Tango Therapeutics from January to August 2019, and held the position of Research Assistant at Morphic Therapeutic from March to July 2018. Additionally, Michaela worked as a Drug Discovery Co-op at XTuit Pharmaceuticals, Inc. in early 2018. Michaela is pursuing a Graduate Degree in Biology at Harvard Extension School, with an expected graduation date in May 2025, following a Bachelor's degree from Northeastern University earned in May 2020.
Morphic Therapeutic
1 followers
Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.